Optimi Health (OPTI) Price & Analysis

Compare

38 Followers

OPTI Stock Chart & Stats

C$0.32

>-C$0.01(-2.38%)

At close: Jan 08 4:00 PM EST

C$0.32

>-C$0.01(-2.38%)

Day’s Range― - ―

52-Week RangeC$0.11 - C$0.42

Previous CloseN/A

Volume13.36K

Average Volume (3M)169.72K

Market Cap

C$36.65M

Enterprise ValueC$41.70M

Total Cash (Recent Filing)C$1.15M

Total Debt (Recent Filing)C$6.68M

Price to Earnings (P/E)―

Beta0.52

Next Earnings

May 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding96,438,170

10 Day Avg. Volume137,724

30 Day Avg. Volume169,715

Financial Highlights & Ratios

PEG Ratio0.24

Price to Book (P/B)5.70

Price to Sales (P/S)87.81

P/FCF Ratio-13.78

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Positive Equity CushionDespite operational losses, a positive equity position and a sizable asset base relative to current revenue give the company a tangible balance-sheet buffer. This cushion helps absorb near-term losses, supports licensing requirements and improves chances of securing financing over the next several months.

Improving Cash Burn TrendYear-over-year improvement in operating and free cash flow signals the company is reducing its cash consumption. An improving burn rate extends runway and reduces immediate financing pressure, giving management more time to execute operational improvements or scale revenue before additional capital is required.

Exposure To Structural Psychedelics/mental-health GrowthOperating in the emerging psychedelics and functional mushroom markets gives long-term exposure to secular demand for novel mental-health therapies and wellness products. A regulated production and formulation capability positions the company to serve licensed medical channels and growing consumer segments as regulations evolve.

Bears Say

Negative Margins & Deep Operating LossesSharply negative gross margin and continued large operating losses indicate the current cost structure is not supported by sales. Unless margins recover through pricing, scale, or lower costs, persistent losses will deplete equity, limit reinvestment, and impair the firm's ability to reach sustainable profitability.

Persistent Negative Cash FlowConsistent negative operating and free cash flow forces reliance on external financing or asset sales to fund operations. This constrains strategic flexibility, raises dilution or refinancing risk, and hampers the company's ability to invest in commercial scale-up or meet regulatory and manufacturing commitments over the medium term.

Rising Leverage Reduces Financial FlexibilityA material increase in debt, with debt roughly equal to equity, weakens financial flexibility while the business remains cash-flow negative. Higher leverage raises interest and covenant risk, limits capacity for growth investments, and increases vulnerability to funding shocks if operating performance does not improve.

Optimi Health News

Optimi Health Expands Australian Footprint With Psilocybin Export for TRD

Optimi Health ( ($TSE:OPTI) ) has shared an announcement. Optimi Health has completed the export of its GMP-manufactured...

9h ago

Optimi Health Expands MDMA-Assisted PTSD Treatments Across Australian Clinics

Optimi Health ( ($TSE:OPTI) ) has shared an update. Optimi Health has begun the first MDMA-assisted treatments of...

2d ago

Optimi Health Ships MDMA to Australia for PTSD Treatment Programs

Optimi Health ( ($TSE:OPTI) ) has issued an update. Optimi Health has completed its first MDMA export of...

10d ago

Optimi Health Begins 2026 Shipments of MDMA and Psilocybin Capsules to Australia

Optimi Health ( ($TSE:OPTI) ) has provided an update. Optimi Health has completed its first 2026 production cycle...

24d ago

Optimi Health Grants Equity Incentives and Launches New Investor Awareness Campaigns

An announcement from Optimi Health ( ($TSE:OPTI) ) is now available. Optimi Health has approved an equity incentive...

1M ago

Optimi Health to Court Institutional Investors at Sidoti Micro-Cap Conference

Optimi Health ( ($TSE:OPTI) ) has shared an announcement. Optimi Health Corp. will present at the Sidoti Micro-Cap...

1M ago

Optimi Health Adds Risk Management Veteran Jason Mosberian to Board

An update from Optimi Health ( ($TSE:OPTI) ) is now available. Optimi Health has appointed Jason Mosberian to...

2M ago

Optimi Health to Supply MDMA for Israeli PTSD Clinical Trial

Optimi Health ( ($TSE:OPTI) ) has issued an announcement. Optimi Health has been chosen to supply MDMA capsules...

3M ago

Optimi Health Achieves GMP Compliance and Enhances Market Liquidity

The latest update is out from Optimi Health ( ($TSE:OPTI) ). Optimi Health Corp. has successfully passed its...

4M ago

Optimi Health’s Psilocybin Capsules Join Medibank’s Expanded Mental Health Program

An announcement from Optimi Health ( ($TSE:OPTI) ) is now available. Optimi Health’s 5mg psilocybin capsules have been...

5M ago

OPTI FAQ

What was Optimi Health’s price range in the past 12 months?

Optimi Health lowest stock price was C$0.10 and its highest was C$0.42 in the past 12 months.

What is Optimi Health’s market cap?

Optimi Health’s market cap is C$36.65M.

When is Optimi Health’s upcoming earnings report date?

Optimi Health’s upcoming earnings report date is May 27, 2026 which is in 97 days.

How were Optimi Health’s earnings last quarter?

Currently, no data Available

Is Optimi Health overvalued?

According to Wall Street analysts Optimi Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Optimi Health pay dividends?

Optimi Health does not currently pay dividends.

What is Optimi Health’s EPS estimate?

Optimi Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Optimi Health have?

Optimi Health has 96,438,170 shares outstanding.

What happened to Optimi Health’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Optimi Health?

Currently, no hedge funds are holding shares in TSE:OPTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Optimi Health

Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.